These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31027422)

  • 21. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability.
    Chez MG; Burton Q; Dowling T; Chang M; Khanna P; Kramer C
    J Child Neurol; 2007 May; 22(5):574-9. PubMed ID: 17690064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
    Kulkarni J; Thomas N; Hudaib AR; Gavrilidis E; Grigg J; Tan R; Cheng J; Arnold A; Gurvich C
    CNS Drugs; 2018 Feb; 32(2):179-187. PubMed ID: 29549516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta-analysis.
    Elnaiem W; Benmelouka AY; Elgendy AMN; Abdelgalil MS; Brimo Alsaman MZ; Mogheeth A; Ali MM; Yousof SM
    Hum Psychopharmacol; 2022 Sep; 37(5):e2841. PubMed ID: 35315131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder.
    Wink LK; Adams R; Horn PS; Tessier CR; Bantel AP; Hong M; Shaffer RC; Pedapati EV; Erickson CA
    J Autism Dev Disord; 2018 Sep; 48(9):3051-3060. PubMed ID: 29644582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.
    Weinreb RN; Liebmann JM; Cioffi GA; Goldberg I; Brandt JD; Johnson CA; Zangwill LM; Schneider S; Badger H; Bejanian M
    Ophthalmology; 2018 Dec; 125(12):1874-1885. PubMed ID: 30082073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
    Rezaei F; Mohammad-Karimi M; Seddighi S; Modabbernia A; Ashrafi M; Salehi B; Hammidi S; Motasami H; Hajiaghaee R; Tabrizi M; Akhondzadeh S
    J Clin Psychopharmacol; 2013 Jun; 33(3):336-42. PubMed ID: 23609382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders.
    Minshawi NF; Wink LK; Shaffer R; Plawecki MH; Posey DJ; Liu H; Hurwitz S; McDougle CJ; Swiezy NB; Erickson CA
    Mol Autism; 2016; 7():2. PubMed ID: 26770664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.
    Owley T; Salt J; Guter S; Grieve A; Walton L; Ayuyao N; Leventhal BL; Cook EH
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):517-24. PubMed ID: 17069541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.
    Handen BL; Anagnostou E; Aman MG; Sanders KB; Chan J; Hollway JA; Brian J; Arnold LE; Capano L; Williams C; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Peleg N; Odrobina D; McAuliffe-Bellin S; Marler S; Wong T; Wagner A; Hadjiyannakis S; Macklin EA; Veenstra-VanderWeele J
    J Am Acad Child Adolesc Psychiatry; 2017 Oct; 56(10):849-856.e6. PubMed ID: 28942807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
    JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Keck PE; Hsu HA; Papadakis K; Russo J
    Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
    Zimmerman AW; Singh K; Connors SL; Liu H; Panjwani AA; Lee LC; Diggins E; Foley A; Melnyk S; Singh IN; James SJ; Frye RE; Fahey JW
    Mol Autism; 2021 May; 12(1):38. PubMed ID: 34034808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
    Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of memantine in children and adolescents with pervasive developmental disorders.
    Erickson CA; Posey DJ; Stigler KA; Mullett J; Katschke AR; McDougle CJ
    Psychopharmacology (Berl); 2007 Mar; 191(1):141-7. PubMed ID: 17016714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.
    Ichikawa H; Hiratani M; Yasuhara A; Tsujii N; Oshimo T; Ono H; Tadori Y
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):84-94. PubMed ID: 28941259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
    Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT;
    Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial.
    Lindelof K; Bendtsen L
    Cephalalgia; 2009 Mar; 29(3):314-21. PubMed ID: 19220313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
    Wink LK; Minshawi NF; Shaffer RC; Plawecki MH; Posey DJ; Horn PS; Adams R; Pedapati EV; Schaefer TL; McDougle CJ; Swiezy NB; Erickson CA
    Mol Autism; 2017; 8():2. PubMed ID: 28138381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
    Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
    N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.